BPC-157 + GHK-Cu + TB-500

This triple-peptide formulation enables multi-pathway exploration of cellular protection, tissue-repair signalling, and extracellular-matrix–related responses. BPC157 is commonly used to investigate vascular support pathways and cell-survival behaviour. GHK-CU, a copper-binding tripeptide, is studied for its influence on collagen expression and extracellular matrix regulation. TB500, a fragment of Thymosin Beta-4, supports research into actin remodelling and cell-migration dynamics.

Common research applications include:

• Modelling angiogenic and extracellular-matrix signalling interactions

• Studying actin-driven cell-repair and structural-recovery processes

• Assessing synergistic or independent peptide-driven cellular responses

• Comparing triple-peptide data with single-compound controls

All components provide well-characterised behaviour under laboratory conditions, supporting reproducible mechanistic studies with reliable dose-response evaluation. This combination is suited to advanced research programs requiring integrated cellular mechanics and repair-pathway modelling.

This product is supplied strictly as a high-purity laboratory reagent. It is not approved for human or veterinary administration, therapeutic or diagnostic use, or for any clinical application. Proper laboratory safety standards and regulatory compliance are required.

This BPC157 + GHK-CU + TB500 peptide blend is used in controlled studies involving angiogenic regulation, cellular-matrix behaviour, and actin-linked repair mechanisms within regulated environments.

For research use only. Not for human consumption.